Haemophilia

Papers
(The H4-Index of Haemophilia is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Utilization and optimization of an electronic self‐administered bleeding assessment tool (E‐Self BAT) for the screening of pediatric bleeding disorders in the hematology clinic73
Cross‐sectional study evaluating the association of haemophilia‐related distress and clinically relevant outcomes48
Issue Information47
Deciphering a novel complex inversion affecting F8 in a family with severe haemophilia A by optical genome mapping47
AUTHOR INDEX37
Diminished cortical bone density of long bones among children with haemophilic arthropathy34
32
American Thrombosis and Hemostasis Network: National Bleeding Disorders Foundation Data Commons: Better Together26
Measurement of recombinant porcine factor VIII in patients with congenital haemophilia A and inhibitors in the presence of emicizumab26
COMMITTEE LIST25
Arthroscopic ankle surgery in people with haemophilia25
Safety and efficacy of a self‐induced myofascial release protocol using a foam roller in patients with haemophilic knee arthropathy24
Determining the approximate factor VIII level of patients with severe haemophilia A on emicizumab using in vivo global haemostasis assays24
Preoperative bleeding risk assessment with ISTH‐BAT and laboratory tests in patients undergoing elective surgery: A prospective cohort study24
AUTHOR INDEX23
Exploring a potential role for selective COX‐2 inhibitors for the prevention of hemophilic arthropathy23
Committee List22
Assessing the factors affecting the accessibility of primary dental care for people with haemophilia21
Cross‐Cultural Translation of the Adolescent Menstrual Bleeding Questionnaire (AMBQ)20
Modulation of Haemostatic Balance in Combined von Willebrand Disease and Antithrombin Deficiency: A Comprehensive Family Study20
Bleed treatment with eptacog beta (rFVIIa) results in a low incidence of rebleeding in adult and adolescent patients with haemophilia A or B with inhibitors20
Giving Choice a Voice: Commentary on Development of the World Federation of Hemophilia Shared Decision‐Making Tool20
0.18464398384094